0001437749-22-018053.txt : 20220728 0001437749-22-018053.hdr.sgml : 20220728 20220728212357 ACCESSION NUMBER: 0001437749-22-018053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220726 FILED AS OF DATE: 20220728 DATE AS OF CHANGE: 20220728 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: E&Investment, Inc. CENTRAL INDEX KEY: 0001796144 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 221116959 BUSINESS ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 00000 BUSINESS PHONE: 82-2-501-3714 MAIL ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER STREET 2: B/D 326, TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: E&Healthcare Investment Fund II CENTRAL INDEX KEY: 0001799534 STATE OF INCORPORATION: M5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 221116958 BUSINESS ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 BUSINESS PHONE: 82-2-501-3714 MAIL ADDRESS: STREET 1: 16TH FLOOR, YEOKSAM I-TOWER, 326 STREET 2: TEHERAN-RO, GANGNAM-GU CITY: SEOUL STATE: M5 ZIP: 06211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 rdgdoc.xml FORM 4 X0306 4 2022-07-26 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001796144 E&Investment, Inc. C/O NEUROBO PHARMACEUTICALS, INC. 200 BERKELEY STREET, OFFICE 19TH FLOOR BOSTON, MA 02116 1 0001799534 E&Healthcare Investment Fund II C/O NEUROBO PHARMACEUTICALS, INC. 200 BERKELEY STREET, OFFICE 19TH FLOOR BOSTON, MA 02116 1 Common Stock 2022-07-26 4 J 0 1445267 0 D 2890533 I Held by The E&Healthcare Investment Fund II Common Stock 140147 D Common Stock 1121190 I Held by The E&Healthcare Investment Fund No. 6 Common Stock 1864799 I Held by The E&Healthcare Investment Fund No. 7 E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration. These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc. E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II. These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc. These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc. /s/ E&I Investment, Inc., By: Na Yeon Kim, CEO 2022-07-28 /s/ The E&Healthcare Investment Fund II, By: Na Yeon Kim, Representative Director 2022-07-28